Annual report
8095.TEDINET S100XN2T
Period2024-12-01 → 2025-11-30
Filed2026-02-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 151
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.7bn | 2024-12-01 → 2025-11-30 | Cons. | Net sales |
| Revenue | ¥58.0bn | 2023-12-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-12-01 → 2023-11-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.0bn | 2024-12-01 → 2025-11-30 | Cons. | Operating income |
| Operating income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2024-12-01 → 2025-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-12-01 → 2023-11-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.9bn | 2024-12-01 → 2025-11-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.5bn | 2023-12-01 → 2024-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.2bn | 2024-12-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.2bn | 2022-12-01 → 2023-11-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥579m | 2021-12-01 → 2022-11-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.2bn | 2024-12-01 → 2025-11-30 | Cons. | Profit loss |
| Net income | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss |
| Total assets | ¥75.4bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥64.6bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥67.3bn | at 2023-11-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥63.6bn | at 2022-11-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥63.6bn | at 2021-11-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥48.0bn | at 2025-11-30 | Cons. | Liabilities |
| Total liabilities | ¥39.3bn | at 2024-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.4bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥28.6bn | at 2023-11-30v | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥27.0bn | at 2021-11-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.2bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.1bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-11-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2022-11-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥10.8bn | at 2021-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.4bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.8bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2022-12-01 → 2023-11-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥742m | 2021-12-01 → 2022-11-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.6bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.9bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.8bn | 2022-12-01 → 2023-11-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2021-12-01 → 2022-11-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.4bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥6.2bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2022-12-01 → 2023-11-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2021-12-01 → 2022-11-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥54.23 | 2024-12-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-63.18 | 2023-12-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.47 | 2022-12-01 → 2023-11-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥670.86 | at 2025-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥625.15 | at 2024-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥719.53 | at 2023-11-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥685.24 | at 2022-11-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥677.09 | at 2021-11-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 35.9% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2023-11-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.4% | 2024-12-01 → 2025-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -9.4% | 2023-12-01 → 2024-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2022-12-01 → 2023-11-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.1% | 2021-12-01 → 2022-11-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-12-01 → 2021-11-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,543 | at 2025-11-30 | Cons. | Number of employees |
| Employees | 1,420 | at 2024-11-30 | Cons. | Number of employees |
| Employees | 1,404 | at 2023-11-30v | Cons. | Number of employees |
| Employees | 1,383 | at 2022-11-30v | Cons. | Number of employees |
| Employees | 1,368 | at 2021-11-30d | Cons. | Number of employees |
| Revenue | ¥3.8bn | 2024-12-01 → 2025-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥2.9bn | 2023-12-01 → 2024-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥2.8bn | 2022-12-01 → 2023-11-30v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥2.8bn | 2021-12-01 → 2022-11-30v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥23.0bn | 2020-12-01 → 2021-11-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2020-12-01 → 2021-11-30d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥693m | 2024-12-01 → 2025-11-30 | Standalone | Operating income |
| Operating income | ¥84m | 2023-12-01 → 2024-11-30 | Standalone | Operating income |
| Ordinary income | ¥181m | 2024-12-01 → 2025-11-30 | Standalone | Ordinary income |
| Ordinary income | −¥29m | 2023-12-01 → 2024-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥209m | 2022-12-01 → 2023-11-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2021-12-01 → 2022-11-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥304m | 2020-12-01 → 2021-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥406m | 2024-12-01 → 2025-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥214m | 2023-12-01 → 2024-11-30 | Standalone | Income before income taxes |
| Net income | ¥294m | 2024-12-01 → 2025-11-30 | Standalone | Profit loss |
| Net income | ¥92m | 2023-12-01 → 2024-11-30 | Standalone | Profit loss |
| Net income | ¥702m | 2022-12-01 → 2023-11-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥831m | 2021-12-01 → 2022-11-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥788m | 2020-12-01 → 2021-11-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥37.5bn | at 2025-11-30 | Standalone | Assets |
| Total assets | ¥31.0bn | at 2024-11-30 | Standalone | Assets |
| Total assets | ¥32.7bn | at 2023-11-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥30.1bn | at 2022-11-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥30.2bn | at 2021-11-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥24.1bn | at 2025-11-30 | Standalone | Liabilities |
| Total liabilities | ¥17.3bn | at 2024-11-30 | Standalone | Liabilities |
| Net assets / equity | ¥13.4bn | at 2025-11-30 | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2024-11-30 | Standalone | Net assets |
| Net assets / equity | ¥14.6bn | at 2023-11-30v | Standalone | Net assets |
| Net assets / equity | ¥13.9bn | at 2022-11-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥14.0bn | at 2021-11-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2025-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥568m | at 2024-11-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥7.29 | 2024-12-01 → 2025-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.32 | 2023-12-01 → 2024-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2022-12-01 → 2023-11-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.88 | 2021-12-01 → 2022-11-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.27 | 2020-12-01 → 2021-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥21.16 | 2020-12-01 → 2021-11-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥18 | 2024-12-01 → 2025-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2023-12-01 → 2024-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2022-12-01 → 2023-11-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2021-12-01 → 2022-11-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2020-12-01 → 2021-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥331.29 | at 2025-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥340.64 | at 2024-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥370.38 | at 2023-11-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥352.82 | at 2022-11-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.47 | at 2021-11-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.7% | at 2025-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2024-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.8% | at 2023-11-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.2% | at 2022-11-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.3% | at 2021-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.2% | 2024-12-01 → 2025-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.7% | 2023-12-01 → 2024-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2022-12-01 → 2023-11-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2021-12-01 → 2022-11-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-12-01 → 2021-11-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 41,097,566 | at 2025-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,982,832 | at 2024-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,884,504 | at 2023-11-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,772,366 | at 2022-11-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,630,087 | at 2021-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 96 | at 2025-11-30 | Standalone | Number of employees |
| Employees | 95 | at 2024-11-30 | Standalone | Number of employees |
| Employees | 93 | at 2023-11-30v | Standalone | Number of employees |
| Employees | 105 | at 2022-11-30v | Standalone | Number of employees |
| Employees | 109 | at 2021-11-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 84
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-12-01 → 2025-11-30 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-11-30 | 11 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-11-30 | ¥64m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-11-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-11-30 | −¥363m |
| Reconciling Itemsreconciling | depreciation | 2024-12-01 → 2025-11-30 | ¥387m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-11-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-11-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-11-30 | −¥80m |
| Fine Chemicalsreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥1.1bn |
| Fine Chemicalsreportable segment | employees | at 2025-11-30 | 567 pure |
| Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥23.3bn |
| Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥22.3bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥924m |
| Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥909m |
| Health And Beauty Care Foodreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥62m |
| Health And Beauty Care Foodreportable segment | employees | at 2025-11-30 | 301 pure |
| Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥18.3bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥18.2bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥76m |
| Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥700m |
| Industrial Chemicalsreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥325m |
| Industrial Chemicalsreportable segment | employees | at 2025-11-30 | 334 pure |
| Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥9.7bn |
| Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥9.7bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥3m |
| Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥733m |
| Medicalreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥260m |
| Medicalreportable segment | employees | at 2025-11-30 | 225 pure |
| Medicalreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥12.8bn |
| Medicalreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥12.4bn |
| Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥321m |
| Medicalreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥1.1bn |
| —segment total | depreciation | 2024-12-01 → 2025-11-30 | ¥1.7bn |
| —segment total | employees | at 2025-11-30 | 1427 pure |
| —segment total | revenue | 2024-12-01 → 2025-11-30 | ¥64.0bn |
| —segment total | revenue external | 2024-12-01 → 2025-11-30 | ¥62.7bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥1.3bn |
| —segment total | segment profit | 2024-12-01 → 2025-11-30 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-12-01 → 2025-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-11-30 | ¥64.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-11-30 | ¥62.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-11-30 | ¥3.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-12-01 → 2024-11-30 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-12-01 → 2024-11-30 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-12-01 → 2024-11-30 | ¥38m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥8m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-12-01 → 2024-11-30 | −¥129m |
| Reconciling Itemsreconciling | depreciation | 2023-12-01 → 2024-11-30 | ¥426m |
| Reconciling Itemsreconciling | revenue | 2023-12-01 → 2024-11-30 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-12-01 → 2024-11-30 | −¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-12-01 → 2024-11-30 | −¥6m |
| Fine Chemicalsreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥1.0bn |
| Fine Chemicalsreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥22.0bn |
| Fine Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥21.1bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥912m |
| Fine Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥219m |
| Health And Beauty Care Foodreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥48m |
| Health And Beauty Care Foodreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥15.3bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥15.2bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥94m |
| Health And Beauty Care Foodreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥623m |
| Industrial Chemicalsreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥323m |
| Industrial Chemicalsreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥10.3bn |
| Industrial Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥10.2bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥70m |
| Industrial Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥807m |
| Medicalreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥211m |
| Medicalreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥11.8bn |
| Medicalreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥11.5bn |
| Medicalreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥315m |
| Medicalreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥1.3bn |
| —segment total | depreciation | 2023-12-01 → 2024-11-30 | ¥1.6bn |
| —segment total | revenue | 2023-12-01 → 2024-11-30 | ¥59.3bn |
| —segment total | revenue external | 2023-12-01 → 2024-11-30 | ¥58.0bn |
| —segment total | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥1.4bn |
| —segment total | segment profit | 2023-12-01 → 2024-11-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-12-01 → 2024-11-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-11-30 | ¥59.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-11-30 | ¥58.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-11-30 | ¥2.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,935
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net ope cf | Prior1YearDuration | 25000000 | JPY |
| Other net ope cf | CurrentYearDuration | -487000000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 5733000000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 4572000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 63000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 64000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -74000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -157000000 | JPY |
| Compensation for damage paid ope cf | Prior1YearDuration | － | JPY |
| Compensation for damage paid ope cf | CurrentYearDuration | -101000000 | JPY |
| Income taxes paid ope cf | Prior1YearDuration | -894000000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration | -1073000000 | JPY |
| Income taxes refund ope cf | Prior1YearDuration | 19000000 | JPY |
| Income taxes refund ope cf | CurrentYearDuration | 89000000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration | 4848000000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | 3393000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YearDuration | -2840000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYearDuration | -2893000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YearDuration | 1000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYearDuration | 3000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration | -357000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -282000000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -153000000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -179000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YearDuration | 480000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration | 503000000 | JPY |
| Subsidies received inv cf | Prior1YearDuration | 14000000 | JPY |
| Subsidies received inv cf | CurrentYearDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YearDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYearDuration | -2629000000 | JPY |
| Proceeds from maturity of insurance funds inv cf | Prior1YearDuration | 8000000 | JPY |
| Proceeds from maturity of insurance funds inv cf | CurrentYearDuration | － | JPY |
| Other net inv cf | Prior1YearDuration | -91000000 | JPY |
| Other net inv cf | CurrentYearDuration | -77000000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -2937000000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -5557000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | -718000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | 3576000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 5000000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -1197000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -1585000000 | JPY |
| Repayments of finance lease obligations fin cf | Prior1YearDuration | -77000000 | JPY |
| Repayments of finance lease obligations fin cf | CurrentYearDuration | -62000000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | Prior1YearDuration | 76000000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | CurrentYearDuration | 10000000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -727000000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -735000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -6000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -0 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |